Remedy has published its first financial statements according to IFRS for the period ended 31 December 2021. The comparative information is presented from the period ended 31 December 2020 and the IFRS transition date is 1 January 2020. Previously the Company has prepared its financial statements, including business review reports and half-year reports, in accordance with the Finnish Accounting Standards (FAS).
| 1,000€ | IFRS 2023 | IFRS 2022 | IFRS 2021 | IFRS 2020 | FAS 2019 | FAS 2018 | FAS 2017 | FAS 2016 |
| Revenue | 33,932 | 43,588 | 44,726 | 41,086 | 31,645 | 20,146 | 17,168 | 16,414 |
| Growth in revenue, % | -22.2% | -2.5% | 8.9% | 29.8% | 57.1% | 17.3% | 4.6% | 19.4% |
| Operating profit (EBIT) | -28,627 | -563 | 11,407 | 7,248 | 6,534 | 0.609 | 2,006 | 3,946 |
| Operating profit, % of revenue | -84.4% | -1.3% | 25.5% | 17.6% | 20.6% | 3.0% | 11.7% | 24.0% |
| Result for the period under review | -22,657 | -1,726 | 8,794 | 5,412 | 5,238 | 0.532 | 1,469 | 3,166 |
| Result for the period under review, % of revenue | -66.8% | -4.0% | 19.7% | 13.2% | 16.6% | 2.6% | 8.6% | 19.3% |
| Balance sheet total | 79,260 | 99,552 | 101,126 | 51,281 | 35,896 | 28,261 | 26,652 | 11,190 |
| Net cash | 23,762 | 49,860 | 51,666 | 18,047 | 15,876 | 20,089 | 20,694 | 10,348 |
| Net gearing, % | -35.1% | -56.4% | -54.4% | -50.0% | -60.2% | -89.9% | -94.8% | -137.3% |
| Equity ratio, % | 85.5% | 88.8% | 86.4% | 70.4% | 73.5% | 79.1% | 81.9% | 74.1% |
| Average number of personnel during review period (FTE) | 334 | 307 | 280 | 265 | 228 | 169 | 139 | 123* |
* The method for calculating the average number of personnel has changed since the 2016 financial year, and the comparable figure is 128.
